Clinical trial
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An…
NCT00443105 · Assaf-Harofeh Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00443105 |
|---|---|
| Title | Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Tacrolimus 0.03% ointment (Protopic) |
| First posted | Mar 5, 2007 |
| Last update posted | Mar 5, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: